46 USD
-2.03 (-4.23%)
45.2 USD
-0.8 (-1.74%)
Overall BRKR gets a fundamental rating of 4 out of 10. We evaluated BRKR against 57 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
Each year in the past 5 years BRKR has been profitable.
In the past 5 years BRKR always reported a positive cash flow from operatings.
1.2 Ratios
BRKR has a Return On Assets of -0.37%. This is in the better half of the industry: BRKR outperforms 64.91% of its industry peers.
With a decent Return On Equity value of -0.97%, BRKR is doing good in the industry, outperforming 64.91% of the companies in the same industry.
BRKR has a Return On Invested Capital of 4.01%. This is in the better half of the industry: BRKR outperforms 68.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 13.99%.
The last Return On Invested Capital (4.01%) for BRKR is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
In the last couple of years the Profit Margin of BRKR has declined.
BRKR's Operating Margin of 8.99% is fine compared to the rest of the industry. BRKR outperforms 66.67% of its industry peers.
BRKR's Operating Margin has declined in the last couple of years.
BRKR has a Gross Margin (48.00%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.50 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRKR has a Altman-Z score (2.50) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.82 indicates that BRKR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.82, BRKR is doing worse than 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.5 |
ROIC/WACC0.42
WACC9.64%
2.3 Liquidity
BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
BRKR has a Current ratio of 1.85. This is in the lower half of the industry: BRKR underperforms 61.40% of its industry peers.
A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
The Quick ratio of BRKR (0.89) is worse than 87.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for BRKR have decreased strongly by -18.37% in the last year.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
Looking at the last year, BRKR shows a small growth in Revenue. The Revenue has grown by 6.10% in the last year.
Measured over the past years, BRKR shows a quite strong growth in Revenue. The Revenue has been growing by 10.19% on average per year.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
The Earnings Per Share is expected to grow by 4.96% on average over the next years.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.14% yearly.
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 23.00, BRKR is valued on the expensive side.
BRKR's Price/Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 82.46% of the companies in the same industry.
BRKR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.34.
BRKR is valuated rather expensively with a Price/Forward Earnings ratio of 21.39.
Based on the Price/Forward Earnings ratio, BRKR is valued cheaper than 82.46% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.56. BRKR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23 | ||
| Fwd PE | 21.39 |
4.2 Price Multiples
82.46% of the companies in the same industry are more expensive than BRKR, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.2 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.57
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
5. Dividend
5.1 Amount
BRKR has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 0.46, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
With a Dividend Yield of 0.41, BRKR pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has paid a dividend for at least 10 years, which is a reliable track record.
As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
46
-2.03 (-4.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners90.24%
Inst Owner Change6.35%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap6.99B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts78
Price Target47.46 (3.17%)
Short Float %12.99%
Short Ratio4.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)4.3%
PT rev (3m)3.33%
EPS NQ rev (1m)-6.25%
EPS NQ rev (3m)-24.54%
EPS NY rev (1m)-4.23%
EPS NY rev (3m)-6.92%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-3.98%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23 | ||
| Fwd PE | 21.39 | ||
| P/S | 2.03 | ||
| P/FCF | N/A | ||
| P/OCF | 74.12 | ||
| P/B | 2.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.2 |
EPS(TTM)2
EY4.35%
EPS(NY)2.15
Fwd EY4.68%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.35%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.57
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.5 |
F-Score5
WACC9.64%
ROIC/WACC0.42
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.74%
EPS Next 2Y-5.53%
EPS Next 3Y1.19%
EPS Next 5Y4.96%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.96%
Revenue Next 2Y1.6%
Revenue Next 3Y2.61%
Revenue Next 5Y3.14%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year14.16%
EBIT Next 3Y13.08%
EBIT Next 5Y8.97%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status of BRUKER CORP (BRKR) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP (BRKR) stock?
The Earnings per Share (EPS) of BRUKER CORP (BRKR) is expected to decline by -20.74% in the next year.
Is the dividend of BRUKER CORP sustainable?
The dividend rating of BRUKER CORP (BRKR) is 4 / 10 and the dividend payout ratio is -96.62%.